Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x<sub>L</sub>

David C.S. Huang(The Royal Melbourne Hospital), Michael Hahne(The Royal Melbourne Hospital), Michael Schroeter(The Royal Melbourne Hospital), Karl Frei(The Royal Melbourne Hospital), A. Fontana(The Royal Melbourne Hospital), Andreas Villunger(The Royal Melbourne Hospital), Kim Newton(The Royal Melbourne Hospital), J Tschopp(The Royal Melbourne Hospital), Andreas Strasser(The Royal Melbourne Hospital)
Proceedings of the National Academy of Sciences
December 21, 1999
Cited by 298Open Access
Full Text

Abstract

Fas activation triggers apoptosis in many cell types. Studies with anti-Fas antibodies have produced conflicting results on Fas signaling, particularly the role of the Bcl-2 family in this process. Comparison between physiological ligand and anti-Fas antibodies revealed that only extensive Fas aggregation, by membrane bound FasL or aggregated soluble FasL consistently triggered apoptosis, whereas antibodies could act as death agonists or antagonists. Studies on Fas signaling in cell lines and primary cells from transgenic mice revealed that FADD/MORT1 and caspase-8 were required for apoptosis. In contrast, Bcl-2 or Bcl-x(L) did not block FasL-induced apoptosis in lymphocytes or hepatocytes, demonstrating that signaling for cell death induced by Fas and the pathways to apoptosis regulated by the Bcl-2 family are distinct.


Related Papers

No related papers found

Powered by citation graph analysis